Invex was featured today in a Small Caps article: https://*********.com.au/invex-therapeutics-phase-three-trial-repurpose-drug-brain-disorder/ OR
"Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder" (if the link doesn't appear).
They interviewed Invex executive director Dr Thomas Duthy:
"For one daily dose of reformulated Exenatide (Presendin™), chronically administered to an estimated 21,500 treatable patients, Invex estimates the annual market is worth $1.6 billion."
“Our discounted enterprise value of $25 million does not reflect Invex’s stage of development or the market opportunity of IIH, particularly when you consider the EU constitutes 60% of the addressable market for IIH and the EMA has provided protocol assistance confirming a single phase three trial will be sufficient to support an application for market approval, subject to demonstrating clinical efficacy and safety. Meanwhile we continue to progress similar discussions with the FDA” he claimed.
- Forums
- ASX - By Stock
- Ann: Invex Successfully Concludes Protocol Assistance with EMA
Invex was featured today in a Small Caps article:...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.004(5.71%) |
Mkt cap ! $5.561M |
Open | High | Low | Value | Volume |
7.1¢ | 7.5¢ | 7.1¢ | $4.091K | 54.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 198734 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 29802 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 198734 | 0.070 |
1 | 10000 | 0.051 |
1 | 200000 | 0.050 |
1 | 60001 | 0.043 |
2 | 510000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 29802 | 1 |
0.075 | 37000 | 1 |
0.076 | 53829 | 2 |
0.077 | 7950 | 1 |
0.080 | 30000 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online